Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute |  |
|---|---|
| Category | Metabolic |
| Evidence grade | A Human trial evidence |
| Regulatory status | Investigational |
| Human amounts | Trial dosesDosing reference Study durations |
| Format | Lyophilized vial |
| Type | Single compound |
| Molecular formula | Not listed |
| Molecular weight | Not listed |
| CAS number | Not listed |
| Sequence | Not listed |
| References | 12 |
| Summary | Pemvidutide (ALT-801) is an investigational once-weekly peptide that activates both the GLP-1 and glucagon receptors with closely matched potency. It has been studied in randomized placebo-controlled trials in fatty liver disease, and a phase 3 trial in MASH was registered in 2026. It is not an approved medicine, and this entry is for research information only. |